Approximately 60–80% of familial ALS patients have a mutation of large effect, such as C9orf72 (40%), SOD1 (20%), FUS (1–5%), and TARBDP (1–5%), which are the most frequent [53]. Here, SOD1 is linked to amyotrophic lateral sclerosis.